, Tracking Stock Market Picks
Enter Symbol:

up 24.36 %

NEURALSTEM INC (CUR) rated Buy with price target $7 by Aegis Capital

Posted on: Wednesday,  Jun 25, 2014  12:00 AM ET by Aegis Capital

Aegis Capital rated Buy NEURALSTEM INC (NASDAQ: CUR) on 06/25/2014. Previously Aegis Capital rated Buy NEURALSTEM INC (NASDAQ: CUR) on 12/10/2012.,
when the stock price was $1.19. Since then, NEURALSTEM INC has gained 24.37% as of 01/14/2016's recent price of $1.48.
If you would have followed the previous Aegis Capital's recommendation on CUR, you would have gained 24.36% of your investment in 1130 days.

Neuralstem, Inc. is a biotechnology company focused on developing and commercializing human neural stem cell technology in the field of regenerative medicine. The Company manufactures its cells both in-house and on an outsource basis. It uses these cells in its research grant and collaborative programs. The Company outsources all the manufacturing and storage of its stem cells to be used in pre-clinical works to Charles River Laboratories, Inc., of Wilmington, Massachusetts. The Charles River facility has the capacity to be used for cell processing under the United States Food and Drug Administration (FDA) determined good manufacturing practices (GMP) in quantities sufficient for its current pre-trial and anticipated future clinical trial needs. As of December 31, 2008, the Company had not identified any specific product.

Aegis Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/25/2014 12:00 AM Buy
4.50 7.00
as of 10/17/2014
1 Week up  3.38 %
1 Month down  -8.68 %
3 Months down  -2.86 %
1 YTD up  4.81 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/10/2012 1:25 PM Buy
1.19 3.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy